Skip to main content
main-content

21.01.2017 | Original Article | Ausgabe 3/2017

Comparative Clinical Pathology 3/2017

Immunohistochemical expression of transforming growth factor Beta-1 in canine mammary carcinomas: its relationships with histologic grading, survival rate, and recurrence

Zeitschrift:
Comparative Clinical Pathology > Ausgabe 3/2017
Autoren:
Massoud Rezaee, Ahmad Reza Movassaghi, Mohsen Maleki

Abstract

Mammary tumors are the most common neoplasm in female dogs and are considered important health problems. In this study we aimed to investigate Transforming Growth Factor Beta-1 (TGF-β1) expression in canine mammary carcinomas (CMCs) by immunohistochemistry and its relationships with histologic grading, survival rate, and recurrence. Tissues were selected from 35 cases of CMCs and were included in a 2-year follow-up study. Immunohistochemistry for detection of TGF-β1 protein was carried out using Avidin-Biotin Complex (ABC) method, and the immunostained slides were scored according to the distribution and intensity of positive reactions. Results indicated that TGF β-1 expression increased significantly in CMCs in comparison to canine normal mammary gland (P < 0.05), 6/35 (17.14%) of tumor samples showed weak immunoreactivity, 15/35 (42.85%) moderate, and 14/35 (40%) showed strong immunoreactivity for TGF-β1. It is also revealed that TGF β-1 increased expression is in significant relationships with higher histologic grades and shorter survival rate after 2 years but not with tumor recurrence.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 3/2017

Comparative Clinical Pathology 3/2017 Zur Ausgabe

Neu im Fachgebiet Pathologie

01.11.2018 | Schwerpunkt: Immunpathologie | Ausgabe 6/2018

Der prädiktive Wert der PD-L1-Diagnostik

22.10.2018 | Schwerpunkt: Immunpathologie | Ausgabe 6/2018

Digitale Pathologie in der Immunonkologie – Aktuelle Chancen und Herausforderungen

Überblick zur Analyse von Immunzellinfiltraten mittels Whole Slide Imaging

22.10.2018 | Schwerpunkt: Immunpathologie | Ausgabe 6/2018

Prognostische Bedeutung von Immunzellinfiltraten in der Tumorpathologie